Corpus ID: 8584726

Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.

  title={Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.},
  author={C. Fenton and G. Plosker},
  journal={American journal of clinical dermatology},
  volume={5 6},
The two-compound product containing calcipotriol 50 microg/g plus betamethasone dipropionate 0.5 mg/g (Dovobet, Daivobet) [referred to here as calcipotriol/betamethasone dipropionate], is a topical treatment for psoriasis vulgaris, combining a vitamin D analog and a corticosteroid. For most adult patients with psoriasis vulgaris on the trunk and limbs, up to 4 weeks of therapy with calcipotriol/betamethasone dipropionate provides an effective and well tolerated treatment. In clinical trials… Expand

Paper Mentions

Interventional Clinical Trial
The purpose of this study is to determine whether using Taclonex ointment under a hydrogel patch is more effective than using the ointment alone in treating psoriasis. Taclonex… Expand
ConditionsPlaque Psoriasis, Psoriasis Vulgaris
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis
Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis
Calcipotriol/Betamethasone Dipropionate
Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review